Increased serum levels of soluble tumor necrosis factor a-receptors in patients undergoing partial liver resection

Hepato-Gastroenterology

Volumn 45, Issue 23, 1998, Pages 1807-1812

  Schroder, J ^a   Gallati, H ^b   Kremer, B ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Interleukin 6; Ischemia; Liver resection; Reperfusion; Soluble tumor necrosis factor receptors; Tumor necrosis factor a

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; GASTRECTOMY; HUMAN; LIVER ISCHEMIA; MALE; PARTIAL HEPATECTOMY; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REPERFUSION;

EID: 0031767624     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hamazaki K, Mimura H, Kato M, Okamoto K, Yunoki M, Mori M, Orita K, Lygidakis NJ: The significance of post-hepatectomy changes in polymorphonuclear elastase and endotoxin levels. Hepato Gasteroenterol 1993; 40:352-355.
2. De la Mata M, Meager A, Rolando N, Daniels HM, Nouri-Aria KT, Goka AK, Eddleston AL, Alexander GJ, Williams R: Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clin Exp Immunol 1990; 82:479-484.
3. Gehr G, Gentz R, Brockhaus M, Loetscher H, Lesslauer M: Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J Immunol 1992; 149:911-917.
4. Ware CF, Crowe PD, Vanarsdale TL, Andrews JL, Grayson MH, Jerzy R, Smith CA, Goodwin RG: Tumor necrosis factor (TNF) receptor expression in T-lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J Immunol 1991; 147:4229-4238.
5. Tartaglia LA, Weber RF, Figsri IS, Reynolds C, Palladino MA, Goedell DV: The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci (USA) 1991; 88:9292-9296.
6. Tsujimoto M, Vilcek J: Tumor necrosis factor receptors in HeLa cells and their regulation by interferon gamma. J Biol Chem 1986; 261:5384-5388.
7. Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL: A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci (USA) 1990; 87:8331-8335.
8. Loetscher H, Pan Y-CE, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W: Molecular cloning and expression of the human 55 kD tumor necrosis factor receptor. Cell 1990; 61:351-359.
9. Smith CA, Davies T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990; 248:1019-1023.
10. Adolf GR, Fruhbeis B: Monoclonal antibodies to soluble human TNF receptor (TNF binding protein) enhance its ability to block TNF toxicity. Cytokine 1992; 4:180-184.
11. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF: TNF soluble receptors protect against excessive TNF alpha during infection and injury. Proc Natl Acad Sci (USA) 1992; 89:4845-4849.
12. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234:470-474.
13. Andus T, Bauer J, Gerok W: Effect of cytokines on the liver. Hepatology 1991; 13:364-375.
14. Maruyama H, Harada A, Kurokawa T, Nonami T, Nakao A, Takagi H: Interleukin-6 as a marker of hepatic metabolism following hepatectomy. Hepato Gastroenterol 1994; 41:222-224.
15. Giradin E, Roux-Lombard P, Grau GE, Suter P, Gallati H, Dayer JM: Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. Immunology 1992; 76:20-23.
16. Bone RC, Sprung CL, Sibbald WJ: Definitions for sepsis and organ failure. Crit Care Med 1992; 20:724-726.
17. Enayati P, Brennan MF, Fong Y: Systemic and liver cytokine activation. Arch Surg 1994; 129:1159-1164.
18. Baigrie RJ, Lamont PM, Whiting S, Morris PJ: Portal endotoxin and cytokine responses during abdominal aortic surgery. Am J Surg 1993; 166:248-251.
19. Fong Y, Moldawer LL, Shires GT, Lowry SF: The biological characteristics of cytokines and their implications in surgical injury. Surg Gynecol Obstet 1990; 170:363-378.
20. Lowry SF: Cytokine mediators of immunity and inflammation. Arch Surg 1993; 128:1235-1241.
21. Wortel CH, van Deventer SJH, Aarden LA, Lygidakis NJ, Buller HR, Hoek FJ, Horikx J, ten Cate JW: Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery 1993; 114:564-570.
22. Steininger R, Roth E, Fugger R, Winkler S, Langle F, Grunberger T, Gotzinger P, Sautner T, Muhlbacher F: Transhepatic metabolism of TNF alpha, IL-6 and endotoxin in the early hepatic reperfusion period after human liver transplantation. Transplantation 1994; 58:179-182.
23. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB: Soluble tumor necrosis factor receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as TNF carriers and TNF antagonists. J Immunol 1993; 151:1548-1561.
24. Aderka D, Engelmann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kushtai G: Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 1991; 51:5602-5607.
25. Schroder J, Stuber F, Gallati H, Schade FU, Kremer B: Pattern of soluble TNF receptors I and II in sepsis. Infection 1995; 23:143-148.
26. Ertel W, Scholl FA, Gallati H, Bonaccio M, Schildberg FW, Trentz O: Increased release of soluble tumor necrosis factor receptors into blood during clinical sepsis. Arch Surg 1994; 129:1330-1337.
27. Hewitt G, Halliday M, McCaigue M, Campbell G, Rowlands B, Diamond T: Mortality, endotoxaemia and cytokine expression after intermittent and continuous hepatic ischaemia. Br J Surg 1995; 82:1424-1426.
28. Hamazaki K, Tagashira H, Mimura T, Doi Y, Yunoki Y, Mori M, Mimura H, Orita K, Lygidakis NJ: Changes in IL-6 and IL-8 after hepatectomy in patients with liver cirrhosis. Hepato Gastroenterol 1995; 42:13-17.
29. Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, Gotoh M, Kishimoto T, Mori T: Interleukin-6 as a new indicator of inflammatory status: Detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992; 111:201-209.
30. Baigrie RJ, Lamont PM, Kwiatkowski D, Dallmann MJ, Morris PJ: Systemic cytokine response after major operation. Br J Surg 1992; 79:757-760.
31. Kragsbjerg P, Holmberg H, Vikerfors T: Serum concentrations of interleukin-6, tumour necrosis factor alpha and C-reactive protein in patients undergoing major operations. Eur J Surg 1995; 161:17-22.
32. Fong Y, Helfgott DG, Brennan MF: Interleukin-6 blockade impedes recovery from experimental hepatectomy. Surg Forum 1993; 49:190-192.